|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Gain on lease modification | |||||
| Restructuring costs | |||||
| Property and equipment and right-of-use asset impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Change in fair value of warrant liability | |||||
| Other income , net | |||||
| Other income (expense), net | |||||
| Net loss | |||||
| Net income (loss) applicable to common stockholders | |||||
| Earnings per share, Basic | |||||
| Earnings per share, Diluted | |||||
| Weighted average common shares outstanding, basic | |||||
| Weighted average common shares outstanding, diluted | |||||
Loading...